Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients.
Katsiari
Christina G
CG
First Department of Propedeutic Medicine, Athens University Medical School, Greece.
Theodossiadis
Panos G
PG
Kaklamanis
Phaedon G
PG
Markomichelakis
Nikos N
NN
Sfikakis
Peter P
PP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D015864:Panuveitis / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab